Ft
Ozempic Maker Novo Nordisk has a weight problem
Ozempic Maker Novo Nordisk has a weight problem
October 23, 2023, 11:39 a.m. ET
The company behind the diabetes and obesity phenomena, Ozempic and Wegovy, is overweight.
Novo Nordisk became Europe’s most valuable company last month, overtaking luxury goods maker LVMH, which itself took the title from food company Nestlé in 2021. All three companies are global stars that dominate the small European stages where they play, but the Danish pharmaceutical company is now an extreme case. This could be one reason why the shares are trading at a lower price than their closest U.S.-listed counterparts. Elie Lilly.
Copyright ©2023 Dow Jones & Company, Inc. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Wj